Andrea Deabreu

1.6k total citations
62 papers, 1.1k citations indexed

About

Andrea Deabreu is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Andrea Deabreu has authored 62 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Pulmonary and Respiratory Medicine, 43 papers in Radiation and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Andrea Deabreu's work include Prostate Cancer Diagnosis and Treatment (56 papers), Prostate Cancer Treatment and Research (56 papers) and Advanced Radiotherapy Techniques (43 papers). Andrea Deabreu is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (56 papers), Prostate Cancer Treatment and Research (56 papers) and Advanced Radiotherapy Techniques (43 papers). Andrea Deabreu collaborates with scholars based in Canada, United States and Australia. Andrea Deabreu's co-authors include Patrick Cheung, Alexandre Mamedov, Liying Zhang, Andrew Loblaw, Laura D’Alimonte, Gerard Morton, Hans T. Chung, Harvey Quon, Geordi Pang and Cyril Danjoux and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and Radiotherapy and Oncology.

In The Last Decade

Andrea Deabreu

61 papers receiving 1.1k citations

Peers

Countries citing papers authored by Andrea Deabreu

Since Specialization

Citations

This map shows the geographic impact of Andrea Deabreu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrea Deabreu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrea Deabreu more than expected).

Fields of papers citing papers by Andrea Deabreu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrea Deabreu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrea Deabreu. The network helps show where Andrea Deabreu may publish in the future.

Co-authorship network of co-authors of Andrea Deabreu

This figure shows the co-authorship network connecting the top 25 collaborators of Andrea Deabreu. A scholar is included among the top collaborators of Andrea Deabreu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrea Deabreu. Andrea Deabreu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Stereotactic Radiation Therapy for Localized Prostate Cancer: 10-Year Outcomes From Three Prospective Trials 2024 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown), Wee Loon Ong, Harvey Quon, Patrick Cheung, William Chu, Hans T. Chung, (unknown), Dilip Panjwani, Yasir Alayed, Geordi Pang, Renée Korol, Libo Zhang, Alexandre Mamedov, Andrea Deabreu, (unknown)	2
2	To Boost or Not to Boost: Pooled Analyses From 2-Fraction SABR Trials for Localized Prostate Cancer 2023 ·International Journal of Radiation OncologyBiologyPhysics ·Wee Loon Ong, Patrick Cheung, Hans T. Chung, William Chu, Jay Detsky, Stanley K. Liu, Gerard Morton, Ewa Szumacher, Chia‐Lin Tseng, Danny Vesprini, Melanie Davidson, Ananth Ravi, Merrylee McGuffin, Liying Zhang, Alexandre Mamedov, Andrea Deabreu, (unknown), Andrew Loblaw	6
3	Elective pelvic nodal irradiation with a simultaneous hypofractionated integrated prostate boost for localized high risk prostate cancer: Long term results from a prospective clinical trial 2021 ·Radiotherapy and Oncology ·Rachel Glicksman, Andrew Loblaw, Gerard Morton, Ewa Szumacher, Hans T. Chung, Danny Vesprini, William Chu, Stanley K. Liu, Richard Choo, Andrea Deabreu, Alexandre Mamedov, Liying Zhang, Patrick Cheung	12
4	Gantry-Based 5-Fraction Elective Nodal Irradiation in Unfavorable-Risk Prostate Cancer: Outcomes From 2 Prospective Studies Comparing SABR Boost With MR Dose-Painted HDR Brachytherapy Boost 2021 ·International Journal of Radiation OncologyBiologyPhysics ·Hima Bindu Musunuru, Patrick Cheung, Danny Vesprini, Stanley K. Liu, William Chu, Hans T. Chung, Gerard Morton, Andrea Deabreu, Melanie Davidson, Ananth Ravi, Joelle Helou, Ling Ho, Liying Zhang, Andrew Loblaw	3
5	Stereotactic pelvic radiotherapy with HDR boost for dose escalation in intermediate and high-risk prostate cancer (SPARE): Efficacy, toxicity and quality of life 2021 ·Radiotherapy and Oncology ·Hima Bindu Musunuru, Patrick Cheung, Danny Vesprini, Stanley K. Liu, William Chu, Hans T. Chung, Gerard Morton, Andrea Deabreu, Melanie Davidson, Ananth Ravi, Joelle Helou, Ling Ho, Liying Zhang, Andrew Loblaw	10
6	Elective nodal ultra hypofractionated radiation for prostate cancer: Safety and efficacy from four prospective clinical trials 2021 ·Radiotherapy and Oncology ·Rachel Glicksman, Stanley K. Liu, Patrick Cheung, Danny Vesprini, William Chu, Hans T. Chung, Gerard Morton, Andrea Deabreu, Melanie Davidson, Ananth Ravi, Hima Bindu Musunuru, Joelle Helou, Ling Ho, Liying Zhang, Andrew Loblaw	10
7	Prostate-specific Antigen Bounce After Stereotactic Body Radiotherapy for Prostate Cancer: A Pooled Analysis of Four Prospective Trials 2019 ·Clinical Oncology ·Soumyajit Roy, Andrew Loblaw, Patrick Cheung, William Chu, Hans T. Chung, Danny Vesprini, (unknown), Amrita Roy Chowdhury, Dilip Panjwani, Geordi Pang, (unknown), Melanie Davidson, Ananth Ravi, Boyd McCurdy, Joelle Helou, Liang Zhang, Alexandre Mamedov, Andrea Deabreu, Harvey Quon	4
8	Phase 1-2 Study of Stereotactic Ablative Radiotherapy Including Regional Lymph Node Irradiation in Patients With High-Risk Prostate Cancer (SATURN): Early Toxicity and Quality of Life 2018 ·International Journal of Radiation OncologyBiologyPhysics ·Hima Bindu Musunuru, Laura D’Alimonte, Melanie Davidson, Ling Ho, Patrick Cheung, (unknown), Stanley K. Liu, William Chu, Hans T. Chung, Ananth Ravi, Andrea Deabreu, Liying Zhang, Kristina Commisso, Andrew Loblaw	41
9	SABR in High-Risk Prostate Cancer: Outcomes From 2 Prospective Clinical Trials With and Without Elective Nodal Irradiation 2018 ·International Journal of Radiation OncologyBiologyPhysics ·Yasir Alayed, Patrick Cheung, Danny Vesprini, Stanley K. Liu, William Chu, Hans T. Chung, Hima Bindu Musunuru, Melanie Davidson, Ananth Ravi, Ling Ho, Andrea Deabreu, Laura D’Alimonte, (unknown), Liying Zhang, Kristina Commisso, Andrew Loblaw	35
10	Dose escalation for prostate stereotactic ablative radiotherapy (SABR): Late outcomes from two prospective clinical trials 2018 ·Radiotherapy and Oncology ·Yasir Alayed, Patrick Cheung, Geordi Pang, Alexandre Mamedov, Laura D’Alimonte, Andrea Deabreu, Kristina Commisso, (unknown), Liang Zhang, Harvey Quon, Hima Bindu Musunuru, Joelle Helou, D.A. Loblaw	41
11	Stereotactic ablative radiotherapy in the treatment of low and intermediate risk prostate cancer: Is there an optimal dose? 2017 ·Radiotherapy and Oncology ·Joelle Helou, Laura D’Alimonte, Harvey Quon, Andrea Deabreu, Kristina Commisso, Patrick Cheung, William Chu, Alexandre Mamedov, Melanie Davidson, Ananth Ravi, Andrew Loblaw	25
12	Long-term Toxicity and Health-related Quality of Life after Single-fraction High Dose Rate Brachytherapy Boost and Hypofractionated External Beam Radiotherapy for Intermediate-risk Prostate Cancer 2017 ·Clinical Oncology ·(unknown), Andrew Loblaw, Hans T. Chung, Patrick Cheung, Ewa Szumacher, Cyril Danjoux, Raxa Sankreacha, (unknown), Andrea Deabreu, Alexandre Mamedov, Gerard Morton	46
13	Dose-escalation of five-fraction SABR in prostate cancer: Toxicity comparison of two prospective trials 2016 ·Radiotherapy and Oncology ·Hima Bindu Musunuru, Harvey Quon, Melanie Davidson, Patrick Cheung, Liying Zhang, Laura D’Alimonte, Andrea Deabreu, Alexandre Mamedov, Andrew Loblaw	55
14	Dose-Escalated Stereotactic Body Radiation Therapy for Prostate Cancer: Quality-of-Life Comparison of Two Prospective Trials 2016 ·Frontiers in Oncology ·Harvey Quon, Hima Bindu Musunuru, Patrick Cheung, Geordi Pang, Alexandre Mamedov, Laura D’Alimonte, Andrea Deabreu, Liying Zhang, Andrew Loblaw	17
15	Accelerated Hypofractioned Postoperative Radiotherapy for Prostate Cancer: A Prospective Phase I/II Study 2015 ·Clinical Oncology ·Adam Gladwish, Andrew Loblaw, Patrick Cheung, Gerard Morton, Hans T. Chung, Andrea Deabreu, Geordi Pang, Alexandre Mamedov	13
16	Prostatic displacement during extreme hypofractionated radiotherapy using volumetric modulated arc therapy (VMAT) 2014 ·Radiation Oncology ·Adam Gladwish, Geordi Pang, Patrick Cheung, Laura D’Alimonte, Andrea Deabreu, Andrew Loblaw	17
17	A comparative study of quality of life in patients with localized prostate cancer treated at a single institution: Stereotactic ablative radiotherapy or external beam+high dose rate brachytherapy boost 2014 ·Radiotherapy and Oncology ·Joelle Helou, Gerard Morton, Liying Zhang, Andrea Deabreu, Laura D’Alimonte, (unknown), Hima Bindu Musunuru, Alexandre Mamedov, Ananth Ravi, Hans T. Chung, Patrick Cheung, Andrew Loblaw	14
18	Intra-fraction Motion during Extreme Hypofractionated Radiotherapy of the Prostate using Pre- and Post-treatment Imaging 2012 ·Clinical Oncology ·Harvey Quon, D.A. Loblaw, Patrick C.F. Cheung, L. Holden, Colin Tang, Geordi Pang, Gerard Morton, Alexandre Mamedov, Andrea Deabreu	26
19	Health-Related Quality of Life After Single-Fraction High-Dose-Rate Brachytherapy and Hypofractionated External Beam Radiotherapy for Prostate Cancer 2010 ·International Journal of Radiation OncologyBiologyPhysics ·Gerard Morton, D.A. Loblaw, Hans T. Chung, (unknown), Raxa Sankreacha, Andrea Deabreu, Liying Zhang, Alexandre Mamedov, Patrick Cheung, Deidre Batchelar, Cyril Danjoux, Ewa Szumacher	57
20	A phase I/II trial of oxidized autologous tumor vaccines during the “watch and wait” phase of chronic lymphocytic leukemia 2004 ·Cancer Immunology Immunotherapy ·David Spaner, (unknown), (unknown), (unknown), Andrea Deabreu	27

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact